Mike Ralston, CEO of Blencowe Resources (BRES) and Manuel Pablo Zúñiga-Pflücker, President and CEO of PetroTal (PTAL) will be presenting and taking live Q&A at focusIR's Investor Webinar on Tuesday 25th February. Please register here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here

Pin to quick picksXps Pensions Share News (XPS)

Share Price Information for Xps Pensions (XPS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 351.00
Bid: 350.00
Ask: 353.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.857%)
Open: 351.00
High: 353.00
Low: 348.00
Prev. Close: 351.00
XPS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Timelines are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors buy following Proximagen deal

Thu, 05th Aug 2010 16:51

Three directors in AIM-quoted biotech sector consolidator Proximagen have added to their holdings following the company's deal with BrainCells Inc for its sabcomeline programme.The Proximagen share price was flat yesterday but the news of the share buying sparked it into life and it ended up 16.5p at 100p. Chief executive Ken Mulvany, finance director James Hunter and non-exec Michael Ashton each bought 15,000 shares at an average price of 84p a share. The shares were bought on 4 and 5 August. Mulvany owns 1.39% of Proximagen, while Hunter owns 20,000 shares and Ashton 41,384 shares. BCI will pay Proximagen an up-front fee and milestone payments worth up to $51m for sabcomeline, as well as royalties on sales. However, most of this cash will not be paid for years and that assumes the clinical trials go as planned. BCI will own the worldwide rights to sabcomeline, which was acquired by Proximagen in February when it paid 6p a share for AIM-quoted Minster Pharmaceuticals, which valued the drug developer at £4.3m. Minster came with £3.5m in cash. Sabcomeline is a treatment for cognitive decline in schizophrenia, which was licensed from GlaxoSmithKline. This is not a core area for Proximagen, which focuses on treatments for neurological conditions. BCI will be responsible for milestone and royalty payments to GSK, as well as the clinical development, regulatory filing and commercialisation of the drug. A phase II trial is planned. In June 2009, Proximagen raised £49m at 140p a share. Proximagen still had £51m in cash and bank deposits at the end of May 2010. There was an outflow from operations of £3.5m in the year to May 2010. Proximagen is valued at £57.4m so there is little upside from its drugs recognised in the share price. Prior to today's share price rise the company was trading at below cash. Minnesota-based Upsher-Smith agreed a similar deal to the BCI one for PRX1, which is a programme for the symptomatic treatment of Parkinson's disease based on an improved version of L-Dopa - a known treatment. The upfront and milestone payments alone could come to $232m (£117m). Again most of these payments are a long way off, although Upsher-Smith did invest $6m at 227p a share in October 2008. Top Director BuyseXpansys (XPS) Director name: Mr Graham DawberAmount purchased: 339,000 @ 7.25p Value: £24,578Proximagen Group (PRX) Director name: Mr James Douglas HunterAmount purchased: 15,000 @ 84.00p Value: £12,600Proximagen Group (PRX) Director name: Mr Kenneth MulvanyAmount purchased: 15,000 @ 84.00p Value: £12,600Proximagen Group (PRX) Director name: Mr Michael AshtonAmount purchased: 15,000 @ 84.00p Value: £12,600MS International (MSI) Director name: Mr David PyleAmount purchased: 10,000 @ 121.50p Value: £12,150Top Director SellsHeavitree.A (HVTA) Director name: Mr Rodney J GlanvilleAmount sold: 7,000 @ 170.00p Value: £11,900
More News
20 Aug 2020 16:03

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
18 Jun 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more
20 Mar 2020 15:57

DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares

DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares

Read more
30 Jan 2020 16:12

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
2 Jan 2020 15:57

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
28 Nov 2019 10:41

XPS Pensions Administration And Investment Units Drive Interim Revenue

XPS Pensions Administration And Investment Units Drive Interim Revenue

Read more
21 Nov 2019 16:00

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
24 Oct 2019 11:54

XPS Pensions "Pleased" With Progress As Revenue Grows In First Half

XPS Pensions "Pleased" With Progress As Revenue Grows In First Half

Read more
5 Sep 2019 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Friday 6 SeptemberMySale Group (re share placing)Berkeley GroupGreene 9 African Oil & 10 11 Design

Read more
26 Jul 2019 17:52

XPS Pensions Non-Executive Jonathan Punter To Leave In September

(Alliance News) - XPS Pensions Group PLC on Friday said Non-Executive Director Jonathan Punter will retire at the annual general meeting, to be held on September 12.Punter was hired as part

Read more
8 Jul 2019 16:40

DIRECTOR DEALINGS: XPS Pensions Co-CEO And Head Of Advisory Buy Shares

(Alliance News) - XPS Pensions Group PLC said Co-Chief Executive Officer Ben Bramhall and Head of Advisory Patrick McCoy, as well as a person closely associated with McCoy, all purchased pensions

Read more
3 Jul 2019 15:12

DIRECTOR DEALINGS: XPS Pensions Co-CEO's Associate Buys Shares

(Alliance News) - XPS Pension Group PLC said that Donna Cuff, a person closely associated with Co-Chief Executive Officer Paul Cuff, purchased around GBP29,633 in shares in a deal on acquired at a

Read more
2 Jul 2019 15:00

Schroders Ups XPS Pensions Holding As BlackRock Disposes

(Alliance News) - XPS Pensions Group PLC said Tuesday Schroders PLC has built its stake in the company while US investment manager BlackRock Inc has sold some of its holding.In two separate

Read more
27 Jun 2019 12:02

XPS Pensions Shares Drop On Bleak Outlook But Confident Long-Term

(Alliance News) - XPS Pensions Group PLC shares were sharply lower in London on Thursday as the pensions firm reported a dramatic rise in annual profit but warned pension revenue will be flat in a

Read more

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.